Steven S. Plotkin

CONFORMATION-SPECIFIC EPITOPES IN ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS RELATED THEREOF

Antibodies to Amyloid Beta

ANTIBODIES TO AMYLOID BETA

COMPOSITIONS AND METHODS FOR INHIBITING TDP-43 AND FUS AGGREGATION

CONFORMATION-SPECIFIC EPITOPES IN ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS RELATED THEREOF

CONFORMATION-SPECIFIC EPITOPES IN TAU, ANTIBODIES THERETO AND METHODS RELATED THEREOF

EPITOPES IN THE RNA RECOGNITION MOTIF 1 (RRM1) OF TDP-43 AND MISFOLDING-SELECTIVE ANTIBODIES THERETO

N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

Compositions comprising cyclic peptides derived from an A-beta peptide

Humanized antibodies binding to amyloid-beta (A-beta)

Methods of reducing toxicity induced by Amyloid beta (A-beta) oligomers using antibodies specific to A-beta oligomers

Epitopes in the RNA recognition motif 1 (RRM1) of TDP-43 and misfolding-selective antibodies thereto

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

C-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO

N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto

EPITOPES IN AMYLOID BETA AND CONFORMATIONALLY-SELECTIVE ANTIBODIES THERETO

Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide

Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions

Methods and systems for predicting misfolded protein epitopes

METHODS AND SYSTEMS FOR PREDICTING MISFOLDED PROTEIN EPITOPES